ApprovalTrail

Approval · Notice of Compliance 87 · 2003

MONITAN: Notice of Compliance 87

Issued April 2, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
87
Date
April 2, 2003
Company
Wyeth CanadaSt. Laurent, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Antihypertensive and anti-anginal agent

Products in this notice

BrandDINStatus today
MONITAN02036290Cancelled Post Market
MONITAN02036436Cancelled Post Market
MONITAN02036444Cancelled Post Market

Medicinal ingredients